Gefitinib is the first in a new class of anti-?cancer drugs known as epidermal growth factor receptor inhibitors. It targets and blocks, within the cell, signaling pathways that are implicated in the growth and survival of cancer cells.
Uses
Gefitinib D8 is used as an internal standard for the quantification of Gefitinib by GC- or LC-mass spectrometry.
